| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-10 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-08 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-07 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.48 | 2e-06 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |